Cannabis-Focused Investment Firm Silver Spike Looks To Raise US$85.0 Million On Its Nasdaq IPO

Management investment firm Silver Spike Investment Corp. (Nasdaq: SSIC) announced on Friday the pricing of its initial public offering on the Nasdaq Stock Market. The company went public on the US-based big board on February 4, 2022 under the ticker symbol “SSIC”.

The offering consists of 6,071,429 common shares at US$14.00 per share for potential total aggregate proceeds of US$85.0 million. The company also gave the underwriters the option to purchase additional 910,714 common shares at the same share price.

Stifel and Piper Sandler are managing the proposed offering as lead underwriters. 

The initial public offering is expected to close on February 9, 2022, subject to customary closing conditions. Net proceeds are expected to be used for its investment objective and strategies, which include debt and investments in the middle-market cannabis companies, and for general corporate purposes.

The newly-organized firm is being managed by health & wellness investment firm Silver Spike Capital.


Information for this briefing was found via Edagr and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

Payfare Completes $65.4 Million IPO, To Begin Trading This Morning

Payfare Inc (TSX: PAY) has completed its initial public offering this morning, raising gross proceeds...

Friday, March 19, 2021, 09:25:08 AM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Electric Vehicle Maker Phoenix Motor Prices US$15.75 Million IPO

Following through its previously announced IPO plan, electric vehicle maker Phoenix Motor Inc. (Nasdaq: PEV)...

Friday, June 10, 2022, 02:19:00 PM

Deep Tech Fund-Backed SPAC Ahren Acquisition Prices US$275 Million Upsized IPO

Special purpose acquisition company Ahren Acquisition Corp. (Nasdaq: AHRNU) started trading publicly on the Nasdaq...

Wednesday, December 15, 2021, 02:12:00 PM

Investment Banks-Sponsored SPAC Roth CH Acquisition V Seeks To Raise US$100 Million In IPO

Special purpose acquisition company Roth CH Acquisition V Co. (Nasdaq: ROCLU) went public on the...

Wednesday, December 1, 2021, 05:01:00 PM